Hexalen is used for the treatment of patients with intermittent ovarian growth taking place after treatment with a cisplatin or alkylating operators based blend. Hexalen works with the development and spread of growth cells, which inevitably brings about their obliteration. The medication has a place with a gathering of medications known as antineoplastics. Endorsed by the U.S. Sustenance and Drug Administration in 1990 and made by MGI Pharma and U.S. Bioscience, Hexalen is accessible in capsule format.
Drug Name: Hexalen
Generic name: Altretamine